WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a key player in the pharmaceutical industry, is set to release its financial outcomes for the first quarter of 2024 on May 7, 2024, following the close of U.S. markets.
Subsequently, the company’s management will host a conference call at 5:00 p.m. ET to discuss corporate updates and future directions. Interested parties can join the live webcast through the “Investors” section on Aclaris Therapeutics’ official website, www.aclaristx.com, ensuring broad accessibility.
The webcast will also be available for replay on the site for a minimum of 30 days, providing stakeholders ample opportunity to engage with the content.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and Microsoft Start.